Explore our pipeline of investigational therapies for cancer treatment and learn more about the phases of development and indications being studied. |
Takeda research and development programs have resulted in an exciting pipeline of potential new treatments that are at various stages of development: Phase 1, ... |
Takeda oncology pipelines and products are focused on hematologic malignancies and solid tumors where we can deliver transformational medicines to patients. |
14 мая 2024 г. · Takeda will showcase its oncology pipeline and product portfolio at the 2024 ASCO Annual Meeting. Learn more. |
2 февр. 2024 г. · The pipeline cull involves three clinical projects: TAK-102 and 103, derived from a 2017 collaboration with the fellow Japanese group Noile- ... |
It is currently in Phase 2b clinical trials and is expected to generate proof-of-concept data by the end of 2023 and a potential readout in 2024. The company's ... |
9 мая 2024 г. · Takeda is committed to growing its business through continued advancement of its Growth & Launch Product portfolio and progression of six promising programs. |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |